[1] |
Florian B, Naig G, Hélène T, et al. The multiple facets of mitochondrial regulations controlling cellular thermogenesis[J]. Cellular and Molecular Life Sciences, 2022,79(10):525. doi: 10.1007/s00018⁃022⁃04523⁃8.
|
[2] |
Dell′Anna ML, Ottaviani M, Kovacs D, et al. Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin[J]. Sci Rep, 2017,7(1):13663. doi: 10.1038/s41598⁃017⁃13961⁃5.
|
[3] |
Jian Z, Li K, Song P, et al. Impaired activation of the Nrf2⁃ARE signaling pathway undermines H2O2⁃induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo[J]. J Invest Dermatol, 2014,134(8):2221⁃2230. doi: 10. 1038/jid.2014.152.
|
[4] |
Divakaruni AS, Brand MD. The regulation and physiology of mitochondrial proton leak[J]. Physiology (Bethesda), 2011,26(3):192⁃205. doi: 10.1152/physiol.00046.2010.
|
[5] |
Kovacs D, Bastonini E, Briganti S, et al. Altered epidermal proliferation, differentiation, and lipid composition: novel key elements in the vitiligo puzzle[J]. Sci Adv, 2022,8(35):eabn 9299. doi: 10.1126/sciadv.abn9299.
|
[6] |
van den Wijngaard R, Wankowicz⁃Kalinska A, Le Poole C, et al. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site[J]. Lab Invest, 2000,80(8):1299⁃1309. doi: 10.1038/labinvest.3780138.
|
[7] |
Aryanian Z, Shirzadian A, Farzaneh S, et al. Metabolic derangement in patients with vitiligo: a cross⁃sectional study[J]. J Investig Med, 2022,70(4):963⁃966. doi: 10.1136/jim⁃2021⁃002062.
|
[8] |
Tang L, Li J, Fu W, et al. Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo[J]. Aging (Albany NY), 2019,11(24):11829⁃11843. doi: 10.18632/aging.102452.
|
[9] |
Ye Z, Chen J, Du P, et al. Metabolomics signature and potential application of serum polyunsaturated fatty acids metabolism in patients with vitiligo[J]. Front Immunol, 2022,13:839167. doi: 10.3389/fimmu.2022.839167.
|
[10] |
位瑞淼, 刘凯新, 王增阳, 等. 脂代谢紊乱在炎症性皮肤病中的作用及相关药物研究进展[J]. 中国药理学与毒理学杂志, 2023,37(1):54⁃62. doi: 10.3867/j.issn.1000⁃3002.2023.01.007.
|
[11] |
Shah F, Patel S, Begum R, et al. Emerging role of tissue resident memory T cells in vitiligo: from pathogenesis to therapeutics[J]. Autoimmun Rev, 2021,20(8):102868. doi: 10.1016/j.autrev.2021. 102868.
|
[12] |
Molodtsov A, Turk MJ. Tissue resident CD8 memory T cell responses in cancer and autoimmunity[J]. Front Immunol, 2018,9:2810. doi: 10.3389/fimmu.2018.02810.
|
[13] |
胡秀红, 任文波, 黄晶. 细胞因子与氨基酸代谢关系的研究进展[J]. 中国免疫学杂志, 2022,38(13):1661⁃1664. doi: 10.3969/ j.issn.1000⁃484X.2022.13.023.
|
[14] |
郑一帆, 黄咏彤, 张永成, 等. 氨基酸代谢重编程在肿瘤细胞及肿瘤相关巨噬细胞极化中的作用研究进展[J]. 山东医药, 2023,63(12):111⁃115.
|
[15] |
Chen JX, Shi Q, Wang XW, et al. Genetic polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and risk of vitiligo in Han Chinese populations: a genotype⁃phenotype correlation study[J]. Br J Dermatol, 2014,170(5):1092⁃1099. doi: 10.1111/bjd.12845.
|
[16] |
Silverberg JI, Silverberg NB. Serum homocysteine as a biomarker of vitiligo vulgaris severity: a pilot study[J]. J Am Acad Dermatol, 2011,64(2):445⁃447. doi: 10.1016/j.jaad.2010. 08.025.
|
[17] |
Tsai TY, Kuo CY, Huang YC. Serum homocysteine, folate, and vitamin B12 levels in patients with vitiligo and their potential roles as disease activity biomarkers: a systematic review and meta⁃analysis[J]. J Am Acad Dermatol, 2019,80(3):646⁃654.e5. doi: 10.1016/j.jaad.2018.08.029.
|
[18] |
Liu W, Liu XY, Qian YT, et al. Urinary metabolomic investigations in vitiligo patients[J]. Sci Rep, 2020,10(1):17989. doi: 10.1038/s41598⁃020⁃75135⁃0.
|
[19] |
Chen J, Zhuang T, Chen J, et al. Homocysteine induces melanocytes apoptosis via PERK⁃eIF2α⁃CHOP pathway in vitiligo[J]. Clin Sci (Lond), 2020,134(10):1127⁃1141. doi: 10. 1042/CS20200218.
|
[20] |
Chen SM, Tang XQ. Homocysteinylation and sulfhydration in diseases[J]. Curr Neuropharmacol, 2022,20(9):1726⁃1735. doi: 10.2174/1570159X20666211223125448.
|
[21] |
Marzabani R, Rezadoost H, Choopanian P, et al. Metabolomic signature of amino acids in plasma of patients with non⁃segmental vitiligo[J]. Metabolomics, 2021,17(10):92. doi: 10. 1007/s11306⁃021⁃01843⁃x.
|
[22] |
Rath M, Müller I, Kropf P, et al. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages[J]. Front Immunol, 2014,5:532. doi: 10.3389/fimmu.2014.00532.
|
[23] |
Krautkramer KA, Fan J, Bäckhed F. Gut microbial metabolites as multi⁃kingdom intermediates[J]. Nat Rev Microbiol, 2021,19(2):77⁃94. doi: 10.1038/s41579⁃020⁃0438⁃4.
|
[24] |
Ni Q, Ye Z, Wang Y, et al. Gut microbial dysbiosis and plasma metabolic profile in individuals with vitiligo[J]. Front Microbiol, 2020,11:592248. doi: 10.3389/fmicb.2020.592248.
|
[25] |
Le Poole IC. Myron Gordon award paper: microbes, T⁃cell diversity and pigmentation[J]. Pigment Cell Melanoma Res, 2021,34(2):244⁃255. doi: 10.1111/pcmr.12957.
|